Company profile
STIMIT AG
Mechanical ventilation is life-saving, especially these days. However during mechanical ventilation, natural lung function is suppressed, and the diaphragm (core breathing muscle) becomes inactive and weak. Often too weak for sufficient breathing, so that patients become adapted to and sometimes dependent on mechanical ventilation (weaning required). STIMIT is developing therapy and medical device to empower patients in intensive care to breathe. The startups technology can non-invasively activate the body's own breathing function. The therapy goal is to maintain breathing muscle function during ventilation, to minimize life-threatening damage to the lungs from mechanical ventilation, and shorten the duration of ventilation. Let's treat more ventilated patients in less time.

Source: startup.ch